{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:20:35Z","timestamp":1794694835799,"version":"4.9.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cyclooxygenase-2 (COX-2) is the key enzyme responsible for the conversion of arachidonic acid to prostaglandins that display pro-inflammatory properties and thus, it is a potential target protein to develop anti-inflammatory drugs. In this study, chemical and bio-informatics approaches have been employed to find a novel potent andrographolide (AGP) analog as a COX-2 inhibitor having better pharmacological properties than aspirin and rofecoxib (controls). The full amino acid sequenced human Alpha fold (AF) COX-2 protein (604AA) was selected and validated for its accuracy against the reported COX-2 protein structures (PDB ID: 5F19, 5KIR, 5F1A, 5IKQ and 1V0X) followed by multiple sequence alignment analysis to establish the sequence conservation. The systematic virtual screening of 237 AGP analogs against AF-COX-2 protein yielded 22 lead compounds based on the binding energy score (&lt;\u2009\u2212 8.0\u00a0kcal\/mol). These were further screened out to 7 analogs by molecular docking analysis and investigated further for ADMET prediction, ligand efficiency metrics calculations, quantum mechanical analysis, MD simulation, electrostatic potential energy (EPE) docking simulation, and MM\/GBSA. In-depth analysis revealed that AGP analog A3 (3-[2-[(1R,4aR,5R,6R,8aR)-6-hydroxy-5,6,8a-trimethyl-2-methylidene-3,4,4a,5,7,8-hexahydro-1H-naphthalen-1-yl]ethylidene]-4-hydroxyoxolan-2-one) forms the most stable complex with the AF-COX-2 showing the least RMSD value (0.37\u2009\u00b1\u20090.03\u00a0nm), a good number of hydrogen bonds (protein\u2013ligand H-bond\u2009=\u200911, and protein H-bond\u2009=\u2009525), minimum EPE score (\u2212 53.81\u00a0kcal\/mol), and lowest MM-GBSA before and after simulation (\u2212 55.37 and \u2212 56.25\u00a0kcal\/mol, respectively) value compared to other analogs and controls. Thus, we suggest that the identified A3 AGP analog could be developed as a promising plant-based anti-inflammatory drug by inhibiting COX-2.<\/jats:p>","DOI":"10.1038\/s41598-023-35192-7","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T12:03:02Z","timestamp":1684497782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Discovery of andrographolide hit analog as a potent cyclooxygenase-2 inhibitor through consensus MD-simulation, electrostatic potential energy simulation and ligand efficiency metrics"],"prefix":"10.1038","volume":"13","author":[{"given":"Priyanka","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Satija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sudandiradoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"key":"35192_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","volume":"69","author":"WL Smith","year":"2000","unstructured":"Smith, W. L., DeWitt, D. L. & Garavito, R. M. Cyclooxygenases: Structural, cellular, and molecular biology. Annu. Rev. Biochem. 69, 145\u2013182 (2000).","journal-title":"Annu. Rev. Biochem."},{"key":"35192_CR2","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/newbio231232a0","volume":"231","author":"JR Vane","year":"1971","unstructured":"Vane, J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 231, 232\u2013235 (1971).","journal-title":"Nat. New Biol."},{"key":"35192_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0090-6980(02)00029-1","volume":"68\u201369","author":"I Morita","year":"2002","unstructured":"Morita, I. Distinct functions of COX-1 and COX-2. Prostaglandins Other Lipid Mediat. 68\u201369, 165\u2013175 (2002).","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"35192_CR4","doi-asserted-by":"publisher","first-page":"37S","DOI":"10.1016\/S0002-9343(99)00115-1","volume":"106","author":"LS Simon","year":"1999","unstructured":"Simon, L. S. Role and regulation of cyclooxygenase-2 during inflammation. Am. J. Med. 106, 37S-42S (1999).","journal-title":"Am. J. Med."},{"key":"35192_CR5","doi-asserted-by":"publisher","first-page":"15069","DOI":"10.1074\/jbc.M116.725713","volume":"291","author":"BJ Orlando","year":"2016","unstructured":"Orlando, B. J. & Malkowski, M. G. Substrate-selective inhibition of cyclooxygeanse-2 by fenamic acid derivatives is dependent on peroxide tone. J. Biol. Chem. 291, 15069\u201315081 (2016).","journal-title":"J. Biol. Chem."},{"key":"35192_CR6","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1021\/cr000068x","volume":"103","author":"CA Rouzer","year":"2003","unstructured":"Rouzer, C. A. & Marnett, L. J. Mechanism of free radical oxygenation of polyunsaturated fatty acids by cyclooxygenases. Chem. Rev. 103, 2239\u20132304 (2003).","journal-title":"Chem. Rev."},{"key":"35192_CR7","doi-asserted-by":"publisher","first-page":"9280","DOI":"10.1074\/jbc.272.14.9280","volume":"272","author":"E Wong","year":"1997","unstructured":"Wong, E., Bayly, C., Waterman, H. L., Riendeau, D. & Mancini, J. A. Conversion of prostaglandin G\/H synthase-1 into an enzyme sensitive to PGHS-2-selective inhibitors by a double His513\u2192Arg and Ile523\u2192Val mutation*. J. Biol. Chem. 272, 9280\u20139286 (1997).","journal-title":"J. Biol. Chem."},{"key":"35192_CR8","doi-asserted-by":"publisher","first-page":"15810","DOI":"10.1074\/jbc.271.26.15810","volume":"271","author":"JK Gierse","year":"1996","unstructured":"Gierse, J. K. et al. A single amino acid difference between cyclooxygenase-1 (COX-1) and \u22122 (COX-2) reverses the selectivity of COX-2 specific inhibitors*. J. Biol. Chem. 271, 15810\u201315814 (1996).","journal-title":"J. Biol. Chem."},{"key":"35192_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.pharmthera.2008.01.002","volume":"118","author":"F Cipollone","year":"2008","unstructured":"Cipollone, F., Cicolini, G. & Bucci, M. Cyclooxygenase and prostaglandin synthases in atherosclerosis: Recent insights and future perspectives. Pharmacol. Ther. 118, 161\u2013180 (2008).","journal-title":"Pharmacol. Ther."},{"key":"35192_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1194\/jlr.R800042-JLR200","volume":"50","author":"CA Rouzer","year":"2009","unstructured":"Rouzer, C. A. & Marnett, L. J. Cyclooxygenases: Structural and functional insights. J. Lipid Res. 50, 29\u201334 (2009).","journal-title":"J. Lipid Res."},{"key":"35192_CR11","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1021\/jm0613166","volume":"50","author":"AL Blobaum","year":"2007","unstructured":"Blobaum, A. L. & Marnett, L. J. Structural and functional basis of cyclooxygenase inhibition. J. Med. Chem. 50, 1425\u20131441 (2007).","journal-title":"J. Med. Chem."},{"key":"35192_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1590-8658(02)80234-1","volume":"34","author":"JL Wallace","year":"2002","unstructured":"Wallace, J. L. Selective cyclooxygenase-2 inhibitors: After the smoke has cleared. Dig. Liver Dis. 34, 89\u201394 (2002).","journal-title":"Dig. Liver Dis."},{"key":"35192_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1146\/annurev.pharmtox.011008.145638","volume":"49","author":"LJ Marnett","year":"2009","unstructured":"Marnett, L. J. The COXIB experience: A look in the rearview mirror. Annu. Rev. Pharmacol. Toxicol. 49, 265\u2013290 (2009).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"35192_CR14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2223\/JPED.1560","volume":"82","author":"MOE Hil\u00e1rio","year":"2006","unstructured":"Hil\u00e1rio, M. O. E., Terreri, M. T. & Len, C. A. Nonsteroidal anti-inflammatory drugs: Cyclooxygenase 2 inhibitors. J. Pediatr. (Rio. J.) 82, 206\u2013212 (2006).","journal-title":"J. Pediatr. (Rio. J.)"},{"key":"35192_CR15","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1211\/0022357021387","volume":"55","author":"N Ahuja","year":"2010","unstructured":"Ahuja, N., Singh, A. & Singh, B. Rofecoxib: An update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects. J. Pharm. Pharmacol. 55, 859\u2013894 (2010).","journal-title":"J. Pharm. Pharmacol."},{"key":"35192_CR16","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1001\/jama.286.8.954","volume":"286","author":"D Mukherjee","year":"2001","unstructured":"Mukherjee, D., Nissen, S. E. & Topol, E. J. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286, 954\u2013959 (2001).","journal-title":"JAMA"},{"key":"35192_CR17","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/FJC.0b013e318157f72d","volume":"50","author":"CD Funk","year":"2007","unstructured":"Funk, C. D. & FitzGerald, G. A. COX-2 inhibitors and cardiovascular risk. J. Cardiovasc. Pharmacol. 50, 470\u2013479 (2007).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"35192_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s10020-021-00358-4","volume":"27","author":"W Chen","year":"2021","unstructured":"Chen, W. et al. New horizons in the roles and associations of COX-2 and novel natural inhibitors in cardiovascular diseases. Mol. Med. 27, 123 (2021).","journal-title":"Mol. Med."},{"key":"35192_CR19","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1161\/01.STR.0000226642.55207.94","volume":"37","author":"F Andersohn","year":"2006","unstructured":"Andersohn, F., Schade, R., Suissa, S. & Garbe, E. Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: A nested case-control study. Stroke 37, 1725\u20131730 (2006).","journal-title":"Stroke"},{"key":"35192_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2018.00976","volume":"9","author":"A Attiq","year":"2018","unstructured":"Attiq, A., Jalil, J., Husain, K. & Ahmad, W. Raging the war against inflammation with natural products. Front. Pharmacol. 9, 1\u201327 (2018).","journal-title":"Front. Pharmacol."},{"key":"35192_CR21","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.jep.2011.03.068","volume":"135","author":"KC Lee","year":"2011","unstructured":"Lee, K. C., Chang, H. H., Chung, Y. H. & Lee, T. Y. Andrographolide acts as an anti-inflammatory agent in LPS-stimulated RAW264.7 macrophages by inhibiting STAT3-mediated suppression of the NF-\u03baB pathway. J. Ethnopharmacol. 135, 678\u2013684 (2011).","journal-title":"J. Ethnopharmacol."},{"key":"35192_CR22","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.bmcl.2015.12.100","volume":"26","author":"L Yuan","year":"2016","unstructured":"Yuan, L. et al. The semi-synthesis of novel andrographolide analogues and anti-influenza virus activity evaluation of their derivatives. Bioorganic Med. Chem. Lett. 26, 769\u2013773 (2016).","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"35192_CR23","doi-asserted-by":"publisher","first-page":"104259","DOI":"10.1016\/j.fitote.2019.104259","volume":"137","author":"J Jiao","year":"2019","unstructured":"Jiao, J. et al. Screening cyclooxygenase-2 inhibitors from Andrographis paniculata to treat inflammation based on bio-affinity ultrafiltration coupled with UPLC-Q-TOF-MS. Fitoterapia 137, 104259 (2019).","journal-title":"Fitoterapia"},{"key":"35192_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrd3410","volume":"10","author":"J Singh","year":"2011","unstructured":"Singh, J., Petter, R. C., Baillie, T. A. & Whitty, A. The resurgence of covalent drugs. Nat. Rev. Drug Discov. 10, 307\u2013317 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"35192_CR25","doi-asserted-by":"publisher","first-page":"112481","DOI":"10.1016\/j.ejmech.2020.112481","volume":"204","author":"QTN Tran","year":"2020","unstructured":"Tran, Q. T. N., Tan, D. W. S., Wong, W. S. F. & Chai, C. L. L. From irreversible to reversible covalent inhibitors: Harnessing the andrographolide scaffold for anti-inflammatory action. Eur. J. Med. Chem. 204, 112481 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"35192_CR26","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1039\/D0NP00049C","volume":"38","author":"QTN Tran","year":"2021","unstructured":"Tran, Q. T. N., Tan, W. S. D., Wong, W. S. F. & Chai, C. L. L. Polypharmacology of andrographolide: Beyond one molecule one target. Nat. Prod. Rep. 38, 682\u2013692 (2021).","journal-title":"Nat. Prod. Rep."},{"key":"35192_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1021\/np5007179","volume":"78","author":"VS Nguyen","year":"2015","unstructured":"Nguyen, V. S. et al. Specificity and inhibitory mechanism of andrographolide and its analogues as antiasthma agents on NF-\u03baB p50. J. Nat. Prod. 78, 208\u2013217 (2015).","journal-title":"J. Nat. Prod."},{"key":"35192_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/molecules26010005","volume":"26","author":"RA Burgos","year":"2021","unstructured":"Burgos, R. A., Alarc\u00f3n, P., Quiroga, J., Manosalva, C. & Hancke, J. Andrographolide, an anti-inflammatory multitarget drug: All roads lead to cellular metabolism. Molecules 26, 5 (2021).","journal-title":"Molecules"},{"key":"35192_CR29","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/j.intimp.2011.09.010","volume":"11","author":"GF Dai","year":"2011","unstructured":"Dai, G. F. et al. Anti-inflammatory effect of novel andrographolide derivatives through inhibition of NO and PGE 2 production. Int. Immunopharmacol. 11, 2144\u20132149 (2011).","journal-title":"Int. Immunopharmacol."},{"key":"35192_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejmech.2018.11.002","volume":"162","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. Synthesis of new ent-labdane diterpene derivatives from andrographolide and evaluation of their anti-inflammatory activities. Eur. J. Med. Chem. 162, 70\u201379 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"35192_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-018-0926-9","volume":"37","author":"Y Peng","year":"2018","unstructured":"Peng, Y. et al. Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway 11 medical and health sciences 1112 oncology and carcinogenesis. J. Exp. Clin. Cancer Res. 37, 1\u201314 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"35192_CR32","doi-asserted-by":"publisher","first-page":"106206","DOI":"10.1016\/j.intimp.2020.106206","volume":"81","author":"W Liu","year":"2020","unstructured":"Liu, W. et al. Andrographolide potentiates PD-1 blockade immunotherapy by inhibiting COX2-mediated PGE2 release. Int. Immunopharmacol. 81, 106206 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"35192_CR33","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.1021\/je100344z","volume":"55","author":"M Chen","year":"2010","unstructured":"Chen, M., Xie, C. & Liu, L. Solubility of andrographolide in various solvents from (288.2 to 323.2) K. J. Chem. Eng. Data 55, 5297\u20135298 (2010).","journal-title":"J. Chem. Eng. Data"},{"key":"35192_CR34","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41586-021-03828-1","volume":"596","author":"K Tunyasuvunakool","year":"2021","unstructured":"Tunyasuvunakool, K. et al. Highly accurate protein structure prediction for the human proteome. Nature 596, 590\u2013596 (2021).","journal-title":"Nature"},{"key":"35192_CR35","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1021\/acs.biochem.5b01378","volume":"55","author":"MJ Lucido","year":"2016","unstructured":"Lucido, M. J., Orlando, B. J., Vecchio, A. J. & Malkowski, M. G. Crystal structure of aspirin\u2013acetylated human cyclooxygenase-2: Insight into the formation of products with reversed stereochemistry. Biochemistry 55, 1226\u20131238 (2016).","journal-title":"Biochemistry"},{"key":"35192_CR36","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1107\/S2053230X16014230","volume":"72","author":"BJ Orlando","year":"2016","unstructured":"Orlando, B. J. & Malkowski, M. G. Crystal structure of rofecoxib bound to human cyclooxygenase-2. Acta Crystallogr. Sect. Struct. Biol. Commun. 72, 772\u2013776 (2016).","journal-title":"Acta Crystallogr. Sect. Struct. Biol. Commun."},{"key":"35192_CR37","doi-asserted-by":"publisher","first-page":"15069","DOI":"10.1074\/jbc.M116.725713","volume":"291","author":"BJ Orlando","year":"2016","unstructured":"Orlando, B. J. & Malkowski, M. G. Substrate-selective Inhibition of cyclooxygeanse-2 by fenamic acid derivatives is dependent on peroxide tone*. J. Biol. Chem. 291, 15069\u201315081 (2016).","journal-title":"J. Biol. Chem."},{"key":"35192_CR38","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"2","author":"C Colovos","year":"1993","unstructured":"Colovos, C. & Yeates, T. O. Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Sci. 2, 1511\u20131519 (1993).","journal-title":"Protein Sci."},{"key":"35192_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1006\/jmbi.1996.0628","volume":"264","author":"J Pontius","year":"1996","unstructured":"Pontius, J., Richelle, J. & Wodak, S. J. Deviations from standard atomic volumes as a quality measure for protein crystal structures. J. Mol. Biol. 264, 121\u2013136 (1996).","journal-title":"J. Mol. Biol."},{"key":"35192_CR40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein, M. & Sippl, M. J. ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 35, 407\u2013410 (2007).","journal-title":"Nucleic Acids Res."},{"key":"35192_CR41","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1110\/ps.0236803","volume":"12","author":"B Wallner","year":"2003","unstructured":"Wallner, B. & Elofsson, A. Can correct protein models be identified?. Protein Sci. 12, 1073\u20131086 (2003).","journal-title":"Protein Sci."},{"key":"35192_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2105-2-5","volume":"2","author":"S Cristobal","year":"2001","unstructured":"Cristobal, S., Zemla, A., Fischer, D., Rychlewski, L. & Elofsson, A. A study of quality measures for protein threading models. BMC Bioinformatics 2, 5 (2001).","journal-title":"BMC Bioinformatics"},{"key":"35192_CR43","doi-asserted-by":"publisher","first-page":"W406","DOI":"10.1093\/nar\/gkw336","volume":"44","author":"D Bhattacharya","year":"2016","unstructured":"Bhattacharya, D., Nowotny, J., Cao, R. & Cheng, J. 3Drefine: An interactive web server for efficient protein structure refinement. Nucleic Acids Res. 44, W406\u2013W409 (2016).","journal-title":"Nucleic Acids Res."},{"key":"35192_CR44","doi-asserted-by":"publisher","first-page":"W363","DOI":"10.1093\/nar\/gky473","volume":"46","author":"W Tian","year":"2018","unstructured":"Tian, W., Chen, C., Lei, X., Zhao, J. & Liang, J. CASTp 3.0: computed atlas of surface topography of proteins. Nucleic Acids Res. 46, W363\u2013W367 (2018).","journal-title":"Nucleic Acids Res."},{"key":"35192_CR45","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"35192_CR46","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/nar\/gki390","volume":"33","author":"VA Simossis","year":"2005","unstructured":"Simossis, V. A. & Heringa, J. PRALINE: A multiple sequence alignment toolbox that integrates homology-extended and secondary structure information. Nucleic Acids Res. 33, 289\u2013294 (2005).","journal-title":"Nucleic Acids Res."},{"key":"35192_CR47","doi-asserted-by":"publisher","first-page":"107591","DOI":"10.1016\/j.jmgm.2020.107591","volume":"98","author":"S Agarwal","year":"2020","unstructured":"Agarwal, S., Dixit, A. & Kashaw, S. K. Ligand and structure based virtual screening of chemical databases to explore potent small molecule inhibitors against breast invasive carcinoma using recent computational technologies. J. Mol. Graph. Model. 98, 107591 (2020).","journal-title":"J. Mol. Graph. Model."},{"key":"35192_CR48","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","volume":"49","author":"S Kim","year":"2021","unstructured":"Kim, S. et al. PubChem in 2021: New data content and improved web interfaces. Nucleic Acids Res. 49, D1388\u2013D1395 (2021).","journal-title":"Nucleic Acids Res."},{"key":"35192_CR49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle, N. M. et al. Open babel: An open chemical toolbox. J. Cheminform. 3, 33 (2011).","journal-title":"J. Cheminform."},{"key":"35192_CR50","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","volume-title":"Chemical biology: Methods and protocols","author":"S Dallakyan","year":"2015","unstructured":"Dallakyan, S. & Olson, A. J. Small-molecule library screening by docking with PyRx. In Chemical biology: Methods and protocols (eds Hempel, J. E. et al.) 243\u2013250 (Springer, 2015). https:\/\/doi.org\/10.1007\/978-1-4939-2269-7_19."},{"key":"35192_CR51","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791 (2009).","journal-title":"J. Comput. Chem."},{"key":"35192_CR52","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/jcc.540150503","volume":"15","author":"R Abagyan","year":"1994","unstructured":"Abagyan, R., Totrov, M. & Kuznetsov, D. ICM\u2014A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation. J. Comput. Chem. 15, 488\u2013506 (1994).","journal-title":"J. Comput. Chem."},{"key":"35192_CR53","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","volume":"49","author":"G Xiong","year":"2021","unstructured":"Xiong, G. et al. ADMETlab 2.0: An integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 49, W5\u2013W14 (2021).","journal-title":"Nucleic Acids Res."},{"key":"35192_CR54","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nrd4163","volume":"13","author":"AL Hopkins","year":"2014","unstructured":"Hopkins, A. L., Keser\u00fc, G. M., Leeson, P. D., Rees, D. C. & Reynolds, C. H. The role of ligand efficiency metrics in drug discovery. Nat. Rev. Drug Discov. 13, 105\u2013121 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"35192_CR55","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.compbiolchem.2017.11.006","volume":"72","author":"AT Onawole","year":"2018","unstructured":"Onawole, A. T., Kolapo, T. U., Sulaiman, K. O. & Adegoke, R. O. Structure based virtual screening of the Ebola virus trimeric glycoprotein using consensus scoring. Comput. Biol. Chem. 72, 170\u2013180 (2018).","journal-title":"Comput. Biol. Chem."},{"key":"35192_CR56","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1016\/j.ddtec.2010.11.003","volume":"7","author":"S Schultes","year":"2010","unstructured":"Schultes, S. et al. Ligand efficiency as a guide in fragment hit selection and optimization. Drug Discov. Today Technol. 7, e157\u2013e162 (2010).","journal-title":"Drug Discov. Today Technol."},{"key":"35192_CR57","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1021\/ml500146d","volume":"5","author":"CW Murray","year":"2014","unstructured":"Murray, C. W. et al. Validity of ligand efficiency metrics. ACS Med. Chem. Lett. 5, 616\u2013618 (2014).","journal-title":"ACS Med. Chem. Lett."},{"key":"35192_CR58","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1016\/j.bmcl.2007.05.038","volume":"17","author":"CH Reynolds","year":"2007","unstructured":"Reynolds, C. H., Bembenek, S. D. & Tounge, B. A. The role of molecular size in ligand efficiency. Bioorg. Med. Chem. Lett. 17, 4258\u20134261 (2007).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"35192_CR59","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1063\/1.464913","volume":"98","author":"AD Becke","year":"1993","unstructured":"Becke, A. D. Density-functional thermochemistry. III: The role of exact exchange. J. Chem. Phys. 98, 5648\u20135652 (1993).","journal-title":"J. Chem. Phys."},{"key":"35192_CR60","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/jcc.1058","volume":"22","author":"VA Rassolov","year":"2001","unstructured":"Rassolov, V. A., Ratner, M. A., Pople, J. A., Redfern, P. C. & Curtiss, L. A. 6\u201331G* basis set for third-row atoms. J. Comput. Chem. 22, 976\u2013984 (2001).","journal-title":"J. Comput. Chem."},{"key":"35192_CR61","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0009-2614(92)85807-M","volume":"197","author":"PMW Gill","year":"1992","unstructured":"Gill, P. M. W., Johnson, B. G., Pople, J. A. & Frisch, M. J. The performance of the Becke\u2013Lee\u2013Yang\u2013Parr (B\u2013LYP) density functional theory with various basis sets. Chem. Phys. Lett. 197, 499\u2013505 (1992).","journal-title":"Chem. Phys. Lett."},{"key":"35192_CR62","doi-asserted-by":"publisher","first-page":"11623","DOI":"10.1021\/j100096a001","volume":"98","author":"PJ Stephens","year":"1994","unstructured":"Stephens, P. J., Devlin, F. J., Chabalowski, C. F. & Frisch, M. J. Ab Initio calculation of vibrational absorption and circular dichroism spectra using density functional force fields. J. Phys. Chem. 98, 11623\u201311627 (1994).","journal-title":"J. Phys. Chem."},{"key":"35192_CR63","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132, 19\u201325 (2015).","journal-title":"SoftwareX"},{"key":"35192_CR64","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1107\/S0907444904011679","volume":"60","author":"AW Sch\u00fcttelkopf","year":"2004","unstructured":"Sch\u00fcttelkopf, A. W. & Van Aalten, D. M. F. PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. Sect. D Biol. Crystallogr. 60, 1355\u20131363 (2004).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"35192_CR65","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00249-011-0700-9","volume":"40","author":"N Schmid","year":"2011","unstructured":"Schmid, N. et al. Definition and testing of the GROMOS force-field versions 54A7 and 54B7. Eur. Biophys. J. 40, 843\u2013856 (2011).","journal-title":"Eur. Biophys. J."},{"key":"35192_CR66","first-page":"989","volume":"64","author":"MSA Abdel-Mottaleb","year":"2021","unstructured":"Abdel-Mottaleb, M. S. A. & Abdel-Mottaleb, Y. Impact of magnesium, zinc, selenium, copper, and iodine food supplements on SARS-CoV, SARS-CoV-2 viruses and their adducts with human ACE2 enzyme: A Computational Based Investigation. Egypt. J. Chem. 64, 989\u2013996 (2021).","journal-title":"Egypt. J. Chem."},{"key":"35192_CR67","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/bioinformatics\/bty879","volume":"35","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. FarPPI: A webserver for accurate prediction of protein-ligand binding structures for small-molecule PPI inhibitors by MM\/PB(GB)SA methods. Bioinformatics 35, 1777\u20131779 (2019).","journal-title":"Bioinformatics"},{"key":"35192_CR68","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier, J. A. et al. ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696\u20133713 (2015).","journal-title":"J. Chem. Theory Comput."},{"key":"35192_CR69","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/jcc.10128","volume":"23","author":"A Jakalian","year":"2002","unstructured":"Jakalian, A., Jack, D. B. & Bayly, C. I. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. J. Comput. Chem. 23, 1623\u20131641 (2002).","journal-title":"J. Comput. Chem."},{"key":"35192_CR70","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang, E. et al. End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: Strategies and applications in drug design. Chem. Rev. 119, 9478\u20139508 (2019).","journal-title":"Chem. Rev."},{"key":"35192_CR71","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/pro.5560070905","volume":"7","author":"J Liang","year":"1998","unstructured":"Liang, J., Woodward, C. & Edelsbrunner, H. Anatomy of protein pockets and cavities: Measurement of binding site geometry and implications for ligand design. Protein Sci. 7, 1884\u20131897 (1998).","journal-title":"Protein Sci."},{"key":"35192_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep06948","volume":"4","author":"HN Banavath","year":"2014","unstructured":"Banavath, H. N., Sharma, O. P., Kumar, M. S. & Baskaran, R. Identification of novel tyrosine kinase inhibitors for drug resistant T315I mutant BCR\u2013ABL: A virtual screening and molecular dynamics simulations study. Sci. Rep. 4, 1\u201311 (2014).","journal-title":"Sci. Rep."},{"key":"35192_CR73","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.procbio.2019.04.018","volume":"82","author":"BK Palaka","year":"2019","unstructured":"V, S. S., Palaka, B. K., Vel, G., Venkatesan, R., Ampasala, D. R. & Periyasamy, L. Identification of novel inhibitors of signal transducer and activator of transcription 3 over signal transducer and activator of transcription 1 for the treatment of breast cancer by in-silico and in-vitro approach. Process Biochem. 82, 153\u2013166 (2019).","journal-title":"Process Biochem."},{"key":"35192_CR74","first-page":"27","volume":"1191","author":"MK Chaudhary","year":"2013","unstructured":"Chaudhary, M. K. et al. Computational evaluation on molecular stability, reactivity, and drug potential of frovatriptan from DFT and molecular docking approach. Comput. Theor. Chem. 1191, 27\u201334 (2013).","journal-title":"Comput. Theor. Chem."},{"key":"35192_CR75","doi-asserted-by":"publisher","first-page":"101248","DOI":"10.1016\/j.jksus.2020.101248","volume":"33","author":"O Noureddine","year":"2021","unstructured":"Noureddine, O., Issaoui, N. & Al-Dossary, O. DFT and molecular docking study of chloroquine derivatives as antiviral to coronavirus COVID-19. J. King Saud Univ. Sci. 33, 101248 (2021).","journal-title":"J. King Saud Univ. Sci."},{"key":"35192_CR76","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1021\/ed5006344","volume":"92","author":"JD Mottishaw","year":"2015","unstructured":"Mottishaw, J. D., Erck, A. R., Kramer, J. H., Sun, H. & Koppang, M. Electrostatic potential maps and natural bond orbital analysis: Visualization and conceptualization of reactivity in Sangers reagent. J. Chem. Educ. 92, 1846\u20131852 (2015).","journal-title":"J. Chem. Educ."},{"key":"35192_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42452-020-2644-0","volume":"2","author":"M Uzzaman","year":"2020","unstructured":"Uzzaman, M., Junaid, M. & Uddin, M. N. Evaluation of anti-tuberculosis activity of some oxotitanium(IV) Schiff base complexes; molecular docking, dynamics simulation and ADMET studies. SN Appl. Sci. 2, 1\u201311 (2020).","journal-title":"SN Appl. Sci."},{"key":"35192_CR78","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1021\/cr020033s","volume":"103","author":"DA Horton","year":"2003","unstructured":"Horton, D. A., Bourne, G. T. & Smythe, M. L. The combinatorial synthesis of bicyclic privileged structures or privileged substructures. Chem. Rev. 103, 893\u2013930 (2003).","journal-title":"Chem. Rev."},{"key":"35192_CR79","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1021\/jm000164q","volume":"43","author":"PJ Hajduk","year":"2000","unstructured":"Hajduk, P. J., Bures, M., Praestgaard, J. & Fesik, S. W. Privileged molecules for protein binding identified from NMR-based screening. J. Med. Chem. 43, 3443\u20133447 (2000).","journal-title":"J. Med. Chem."},{"key":"35192_CR80","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.3390\/molecules25081937","volume":"25","author":"BM El-Haj","year":"2020","unstructured":"El-Haj, B. M. & Ahmed, S. B. M. Metabolic-hydroxy and carboxy functionalization of alkyl moieties in drug molecules: Prediction of structure influence and pharmacologic activity. Molecules 25, 1937 (2020).","journal-title":"Molecules"},{"key":"35192_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-019-4175-4","volume":"25","author":"MA Unal","year":"2019","unstructured":"Unal, M. A., Boyacioglu, B., Unver, H. & Elmali, A. Molecular simulation of PcCel45A protein expressed from Aspergillus nidulans to understand its structure, dynamics, and thermostability. J. Mol. Model. 25, 1. https:\/\/doi.org\/10.1007\/s00894-019-4175-4 (2019).","journal-title":"J. Mol. Model."},{"key":"35192_CR82","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1134\/S0026893308040195","volume":"42","author":"MY Lobanov","year":"2008","unstructured":"Lobanov, M. Y., Bogatyreva, N. S. & Galzitskaya, O. V. Radius of gyration as an indicator of protein structure compactness. Mol. Biol. 42, 623\u2013628 (2008).","journal-title":"Mol. Biol."},{"key":"35192_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-16-S15-P1","volume":"16","author":"CR Chen","year":"2015","unstructured":"Chen, C. R. & Makhatadze, G. I. ProteinVolume: Calculating molecular van der Waals and void volumes in proteins. BMC Bioinformatics 16, 1\u20136 (2015).","journal-title":"BMC Bioinformatics"},{"key":"35192_CR84","doi-asserted-by":"publisher","first-page":"e0265614","DOI":"10.1371\/journal.pone.0265614","volume":"17","author":"IJ Kim","year":"2022","unstructured":"Kim, I. J. & Na, H. An efficient algorithm calculating common solvent accessible volume. PLoS ONE 17, e0265614 (2022).","journal-title":"PLoS ONE"},{"key":"35192_CR85","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12859-015-0531-2","volume":"16","author":"CR Chen","year":"2015","unstructured":"Chen, C. R. & Makhatadze, G. I. ProteinVolume: Calculating molecular van der Waals and void volumes in proteins. BMC Bioinformatics 16, 101 (2015).","journal-title":"BMC Bioinformatics"},{"key":"35192_CR86","doi-asserted-by":"publisher","first-page":"8331","DOI":"10.1073\/pnas.0600118103","volume":"103","author":"JA Wagoner","year":"2006","unstructured":"Wagoner, J. A. & Baker, N. A. Assessing implicit models for nonpolar mean solvation forces: The importance of dispersion and volume terms. Proc. Natl. Acad. Sci. 103, 8331\u20138336 (2006).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"35192_CR87","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00894-009-0454-9","volume":"15","author":"E Durham","year":"2009","unstructured":"Durham, E., Dorr, B., Woetzel, N., Staritzbichler, R. & Meiler, J. Solvent accessible surface area approximations for rapid and accurate protein structure prediction. J. Mol. Model. 15, 1093\u20131108 (2009).","journal-title":"J. Mol. Model."},{"key":"35192_CR88","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/(SICI)1097-0282(19991005)50:4<373::AID-BIP3>3.0.CO;2-U","volume":"50","author":"J Weiser","year":"1999","unstructured":"Weiser, J., Shenkin, P. S. & Still, W. C. Approximate solvent\u2013Accessible surface areas from tetrahedrally directed neighbor densities. Biopolymers 50, 373\u2013380 (1999).","journal-title":"Biopolymers"},{"key":"35192_CR89","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv.12155235.v1","author":"MSA Abdel-Mottaleb","year":"2020","unstructured":"Abdel-Mottaleb, M. S. A. & Abdel-Mottaleb, Y. In search for effective and safe drugs against SARS-CoV-2: Part I] simulated interactions between selected nutraceuticals, ACE2 enzyme and S Protein simple peptide sequences. ChemRxiv https:\/\/doi.org\/10.26434\/chemrxiv.12155235.v1 (2020).","journal-title":"ChemRxiv"},{"key":"35192_CR90","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1080\/07391102.2020.1823884","volume":"40","author":"L Taidi","year":"2022","unstructured":"Taidi, L., Maurady, A. & Britel, M. R. Molecular docking study and molecular dynamic simulation of human cyclooxygenase-2 (COX-2) with selected eutypoids. J. Biomol. Struct. Dyn. 40, 1189\u20131204 (2022).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"35192_CR91","doi-asserted-by":"publisher","first-page":"e0134691","DOI":"10.1371\/journal.pone.0134691","volume":"10","author":"JK Dhanjal","year":"2015","unstructured":"Dhanjal, J. K. et al. Computational structure-based de novo design of hypothetical inhibitors against the anti-inflammatory target COX-2. PLoS ONE 10, e0134691 (2015).","journal-title":"PLoS ONE"},{"key":"35192_CR92","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40538-022-00340-0","volume":"9","author":"KS Jack","year":"2022","unstructured":"Jack, K. S., Asaruddin, M. R. B. & Bhawani, S. A. Pharmacophore study, molecular docking and molecular dynamic simulation of virgin coconut oil derivatives as anti-inflammatory agent against COX-2. Chem. Biol. Technol. Agric. 9, 73 (2022).","journal-title":"Chem. Biol. Technol. Agric."},{"key":"35192_CR93","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00894-021-05016-4","volume":"28","author":"M Sadeghi","year":"2021","unstructured":"Sadeghi, M., Miroliaei, M., Fateminasab, F. & Moradi, M. Screening cyclooxygenase-2 inhibitors from Allium sativum L. compounds: In silico approach. J. Mol. Model. 28, 24 (2021).","journal-title":"J. Mol. Model."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35192-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35192-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35192-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T13:11:56Z","timestamp":1684501916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35192-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["35192"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-35192-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,19]]},"assertion":[{"value":"10 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8147"}}